litlas
ログインアカウント作成

Haidong Dong

1999–2025 年に発表

111
論文数
30,725
被引用数
75
h 指数
108
i10 指数

被引用数

Haidong Dong の年別被引用数1993 年: 被引用 1 件1994 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 13 件2000 年: 被引用 28 件2001 年: 被引用 58 件2002 年: 被引用 72 件2003 年: 被引用 159 件2004 年: 被引用 180 件2005 年: 被引用 179 件2006 年: 被引用 204 件2007 年: 被引用 256 件2008 年: 被引用 281 件2009 年: 被引用 255 件2010 年: 被引用 211 件2011 年: 被引用 238 件2012 年: 被引用 231 件2013 年: 被引用 332 件2014 年: 被引用 397 件2015 年: 被引用 587 件2016 年: 被引用 546 件2017 年: 被引用 554 件2018 年: 被引用 452 件2019 年: 被引用 1,448 件2020 年: 被引用 1,659 件2021 年: 被引用 1,630 件2022 年: 被引用 1,270 件2023 年: 被引用 976 件2024 年: 被引用 1,381 件2025 年: 被引用 698 件2026 年: 被引用 19 件1995〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,985 件、この内訳の 27.7%中国: 引用元論文 3,273 件、この内訳の 22.7%日本: 引用元論文 602 件、この内訳の 4.2%ドイツ: 引用元論文 599 件、この内訳の 4.2%イタリア: 引用元論文 554 件、この内訳の 3.8%イギリス: 引用元論文 520 件、この内訳の 3.6%フランス: 引用元論文 483 件、この内訳の 3.4%韓国: 引用元論文 319 件、この内訳の 2.2%オーストラリア: 引用元論文 315 件、この内訳の 2.2%スペイン: 引用元論文 309 件、この内訳の 2.1%カナダ: 引用元論文 289 件、この内訳の 2%オランダ: 引用元論文 260 件、この内訳の 1.8%
0%27.7%その他 20.1%

機関

分野

  • Medicine56.3%
  • Biochemistry, Genetics and Molecular Biology22.8%
  • Immunology and Microbiology17.7%
  • Engineering1.2%
  • Neuroscience0.9%
  • Materials Science0.3%
  • その他0.8%

トピック

  • Cancer Immunotherapy and Biomarkers15.9%
  • Immunotherapy and Immune Responses8.2%
  • Immune Cell Function and Interaction7.3%
  • CAR-T cell therapy research5.1%
  • Extracellular vesicles in disease4.3%
  • Immune cells in cancer4%
  • その他55.2%

共著者

全論文

検索で開く
  1. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response

    著者: Gang Chen, Alexander C. Huang, Wei Zhang, Gao Zhang, Min Wu, Wei Xu, Zi‐Li Yu, Jiegang Yang, Beike Wang, Honghong Sun, Hou-Fu Xia, Qi‐Wen Man, Wenqun Zhong, Leonardo F. Antelo, Bin Wu, Xuepeng Xiong, Xiaoming Liu, Lei Guan, Ting Li, Shujing Liu, Ruifeng Yang, Youtao Lu, Liyun Dong, Suzanne McGettigan, Rajasekharan Somasundaram, Ravi Radhakrishnan, Gordon B. Mills, Yiling Lu, Junhyong Kim, Youhai H. Chen, Haidong Dong, Yi‐Fang Zhao, Giorgos C. Karakousis, Tara C. Mitchell, Lynn M. Schuchter, Meenhard Herlyn, E. John Wherry, Xiaowei Xu, Wei Guo - Nature 2018 被引用: 2,837

  2. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

    著者: Haidong Dong, Scott E. Strome, Diva R. Salomão, Hideto Tamura, Fumiya Hirano, Dallas B. Flies, Patrick C. Roche, Jun Lü, Gefeng Zhu, Koji Tamada, Vanda A. Lennon, Esteban Celis, Lieping Chen - Nature Medicine 2002 被引用: 5,015

  3. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

    著者: Haidong Dong, Gefeng Zhu, Koji Tamada, Lieping Chen - Nature Medicine 1999 被引用: 2,486

  4. Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma

    著者: Emilien Loeuillard, Jingchun Yang, EeeLN H. Buckarma, Juan Wang, Yuanhang Liu, Caitlin B. Conboy, Kevin D. Pavelko, Ying Li, Daniel R. O’Brien, Chen Wang, Rondell P. Graham, Rory L. Smoot, Haidong Dong, Sumera I. Ilyas - Journal of Clinical Investigation 2020 被引用: 393

  5. B7-H3: A costimulatory molecule for T cell activation and IFN-γ production

    著者: Andrei I. Chapoval, Jian Ni, Julie S. Lau, Ryan A. Wilcox, Dallas B. Flies, Ding Liu, Haidong Dong, Gabriel Sica, Gefeng Zhu, Koji Tamada, Lieping Chen - Nature Immunology 2001 被引用: 1,021

  6. PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression

    著者: Haidong Tang, Yong Liang, Robert A. Anders, Janis M. Taube, Xiangyan Qiu, Aditi Mulgaonkar, Xin Liu, Susan M. Harrington, Jingya Guo, Yangchun Xin, Ya‐Hong Xiong, Kien Nham, William Silvers, Guiyang Hao, Xiankai Sun, Mingyi Chen, Raquibul Hannan, Jian Qiao, Haidong Dong, Hua Peng, Yang-Xin Fu - Journal of Clinical Investigation 2018 被引用: 532

  7. ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression

    著者: Wei Zhang, Wenqun Zhong, Beike Wang, Jiegang Yang, Jingbo Yang, Ziyan Yu, Zhiyuan Qin, Alex Shi, Wei Xu, Cathy Zheng, Lynn M. Schuchter, Giorgos C. Karakousis, Tara C. Mitchell, Ravi K. Amaravadi, Meenhard Herlyn, Haidong Dong, Phyllis A. Gimotty, George Daaboul, Xiaowei Xu, Wei Guo - Developmental Cell 2022 被引用: 144

  8. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

    著者: Tyler J. Curiel, Shuang Wei, Haidong Dong, Xavier Álvarez, Pui Cheng, Peter Mottram, Roman Krzysiek, Keith L. Knutson, Ben Daniel, Maria Zimmermann, Odile David, Matthew E. Burow, Alan N. Gordon, Nina Dhurandhar, Leann Myers, Ruth Berggren, Akseli Hemminki, Ronald D. Alvarez, Dominique Émilie, David T. Curiel, Lieping Chen, Weiping Zou - Nature Medicine 2003 被引用: 1,317

  9. The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8+ T Cell Fitness and Functionality

    著者: Chaofan Li, Bibo Zhu, Young Min Son, Zheng Wang, Li Jiang, Min Xiang, Zhenqing Ye, Kathryn E. Beckermann, Yue Wu, James W. Jenkins, Peter J. Siska, Benjamin G. Vincent, Y. S. Prakash, Tobias Peikert, Brian T. Edelson, Reshma Taneja, Mark H. Kaplan, Jeffrey C. Rathmell, Haidong Dong, Taro Hitosugi, Jie Sun - Immunity 2019 被引用: 250

  10. PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy

    著者: Xinyi Tu, Bo Qin, Yong Zhang, Cheng Zhang, Mohamed M. Kahila, Somaira Nowsheen, Ping Yin, Jian Yuan, Huadong Pei, Hu Li, Jia Yu, Zhiwang Song, Qin Zhou, Fei Zhao, Jiaqi Liu, Chao Zhang, Haidong Dong, Robert W. Mutter, Zhenkun Lou - Molecular Cell 2019 被引用: 267

  11. Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

    著者: Xin Jin, Donglin Ding, Yuqian Yan, Hui Li, Bo Wang, Linlin Ma, Zhenqing Ye, Tao Ma, Qiang Wu, Daniel Nava Rodrigues, Manish Kohli, Rafael E. Jiménez, Liguo Wang, David W. Goodrich, Johann S. de Bono, Haidong Dong, Heshui Wu, Runzhi Zhu, Haojie Huang - Molecular Cell 2018 被引用: 270

  12. Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity

    著者: Wenqun Zhong, Youtao Lu, Xuexiang Han, Jingbo Yang, Zhiyuan Qin, Wei Zhang, Ziyan Yu, Bin Wu, Shujing Liu, Wei Xu, Cathy Zheng, Lynn M. Schuchter, Giorgos C. Karakousis, Tara C. Mitchell, Ravi K. Amaravadi, Ahron Flowers, Phyllis A. Gimotty, Min Xiao, Gordon B. Mills, Meenhard Herlyn, Haidong Dong, Michael J. Mitchell, Junhyong Kim, Xiaowei Xu, Wei Guo - Cell Reports 2023 被引用: 76

  13. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas

    著者: Guoying Zhou, Dave Sprengers, Patrick P.C. Boor, Michail Doukas, Hannah M. Schutz, Shanta Mancham, Alexander Pedroza‐González, Wojciech G. Polak, Jeroen de Jonge, Marcia P. Gaspersz, Haidong Dong, Kris Thielemans, Qiuwei Pan, Jan N.M. IJzermans, Marco J. Bruno, Jaap Kwekkeboom - Gastroenterology 2017 被引用: 427

  14. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

    著者: Wei Ding, Betsy LaPlant, Timothy G. Call, Sameer A. Parikh, José F. Leis, Rong He, Tait D. Shanafelt, Sutapa Sinha, Jennifer Le‐Rademacher, Andrew L. Feldman, Thomas M. Habermann, Thomas E. Witzig, Gregory A. Wiseman, Yi Lin, Erik Asmus, Grzegorz S. Nowakowski, Michael Conte, Deborah A. Bowen, Casey N. Aitken, Daniel L. Van Dyke, Patricia T. Greipp, Xin Liu, Xiaosheng Wu, Henan Zhang, Charla Secreto, Shulan Tian, Esteban Braggio, Linda Wellik, Ivana N. Micallef, David S. Viswanatha, Huihuang Yan, Asher Chanan‐Khan, Neil E. Kay, Haidong Dong, Stephen M. Ansell - Blood 2017 被引用: 412

  15. Immune signatures underlying post-acute COVID-19 lung sequelae

    著者: In Su Cheon, Chaofan Li, Young Min Son, N. Goplen, Yue Wu, Tiffany J. Cassmann, Zheng Wang, Xiaoqin Wei, Jinyi Tang, Yichen Li, H. Marlow, Steven G. Hughes, L. Hammel, Tom Cox, Emma N. Goddery, Katayoun Ayasoufi, Daniela Weiskopf, Jim Boonyaratanakornkit, Haidong Dong, Hu Li, Rana Chakraborty, Aaron J. Johnson, Eric S. Edell, Justin J. Taylor, Mark H. Kaplan, Alessandro Sette, Brian J. Bartholmai, Ryan Kern, Robert Vassallo, Jie Sun - Science Immunology 2021 被引用: 187

  16. Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity

    著者: Fumiya Hirano, Katsumi Kaneko, Hideto Tamura, Haidong Dong, Shengdian Wang, Masao Ichikawa, Cecilia Rietz, Dallas B. Flies, Julie S. Lau, Gefeng Zhu, Koji Tamada, Lieping Chen - Cancer Research 2005 被引用: 1,004

  17. NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

    著者: Ti Wen, Whitney Barham, Ying Li, Henan Zhang, Joanina K. Gicobi, Jacob B. Hirdler, Xin Liu, Hyoungjun Ham, Kodi E. Peterson Martinez, Fabrice Lucien, Roxane R. Lavoie, Hu Li, Cristina Correia, Dileep D. Monie, Zesheng An, Susan M. Harrington, Xiaosheng Wu, Ruifeng Guo, Roxana Dronca, Aaron S. Mansfield, Yiyi Yan, Svetomir N. Markovic, Sean S. Park, Jie Sun, Hong Qin, Minetta C. Liu, George Vasmatzis, Daniel D. Billadeau, Haidong Dong - Cancer Immunology Research 2021 被引用: 84

  18. Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer

    著者: Aaron S. Mansfield, MC Aubry, Justin C. Moser, Susan M. Harrington, Roxana Dronca, S. S. Park, Haidong Dong - Annals of Oncology 2016 被引用: 336

  19. PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-β receptor I versus II

    著者: Liankang Sun, Yuanguo Wang, Xianghu Wang, Amaia Navarro‐Corcuera, Sumera I. Ilyas, Nidhi Jalan‐Sakrikar, Can Gan, Xinyi Tu, Yu Shi, Kangsheng Tu, Qingguang Liu, Zhenkun Lou, Haidong Dong, Arlene H. Sharpe, Vijay H. Shah, Ningling Kang - Cell Reports 2022 被引用: 54

  20. Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma

    著者: Paul L. Crispen, Yuri Sheinin, Timothy J. Roth, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, R. Houston Thompson, Stephen A. Boorjian, Haidong Dong, Bradley C. Leibovich, Michael L. Blute, Eugene D. Kwon - Clinical Cancer Research 2008 被引用: 272

  21. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction

    著者: Benjamin Himes, Timothy E. Peterson, Tristan de Mooij, Luz Milbeth Cumba Garcia, Miyeon Jung, Sarah Uhm, David Z. Yan, Jasmine Tyson, Helen J. Jin‐Lee, Daniel Parney, Yasmina Abukhadra, Michael P. Gustafson, Allan B. Dietz, Aaron J. Johnson, Haidong Dong, Rachel L.G. Maus, Svetomir N. Markovic, Fabrice Lucien, Ian F. Parney - Neuro-Oncology 2020 被引用: 95

  22. Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

    著者: Narjust Duma, Azzouqa Abdel-Ghani, Siddhartha Yadav, Katherine P. Hoversten, Clay T. Reed, Andrea Sitek, Elizabeth Ann L. Enninga, Jonas Paludo, Jesus Vera Aguilera, Konstantinos Leventakos, Yanyan Lou, Lisa A. Kottschade, Haidong Dong, Aaron S. Mansfield, Rami Manochakian, Alex A. Adjei, Roxana Dronca - The Oncologist 2019 被引用: 134

  23. PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata

    著者: Brant A. Inman, Thomas J. Sebo, Xavier Frigola, Haidong Dong, Eric J. Bergstralh, Igor Frank, Yves Fradet, Louis Lacombe, Eugene D. Kwon - Cancer 2007 被引用: 441

  24. CX3CR1 identifies PD-1 therapy–responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

    著者: Yiyi Yan, Siyu Cao, Xin Liu, Susan M. Harrington, Wendy Bindeman, Alex A. Adjei, Jin Sung Jang, Jin Jen, Ying Li, Pritha Chanana, Aaron S. Mansfield, Sean S. Park, Svetomir N. Markovic, Roxana Dronca, Haidong Dong - JCI Insight 2018 被引用: 183